查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972597

阿曲庫銨市場：按劑型、給藥途徑、應用、最終用戶和分銷管道分類－2026-2032年全球預測

Atracurium Market by Form, Route Of Administration, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，課外活動市場價值將達到 2.5175 億美元，到 2026 年將成長至 2.6717 億美元，到 2032 年將達到 3.3773 億美元，複合年成長率為 4.28%。

主要市場統計數據
基準年 2025 2.5175億美元
預計年份：2026年 2.6717億美元
預測年份 2032 3.3773億美元
複合年成長率 (%) 4.28%

簡要概述 Atracrium 的臨床作用、藥理特性以及對醫院和重症監護相關人員。

阿曲庫銨因其可預測的、中度的神經肌肉阻斷作用以及不嚴重依賴腎臟或肝臟功能的代謝特性，在麻醉和重症監護領域發揮著獨特而持久的作用。在複雜的外科手術和長期重症監護等因器官功能障礙而導致藥物選擇困難的情況下，臨床醫生高度重視阿曲庫銨的這些藥理特性。阿曲庫銨起效時間和持續時間的平衡以及可靠的安全性使其尤其適用於合併多種併發症的患者群體，並已從一種小眾產品發展成為許多處方集中的核心選擇。

重新構想阿曲庫銨在手術全期和重症監護環境中的應用：新的臨床實踐、監管調整和供應鏈轉型。

由於臨床實踐的改變、監管的改進以及供應鏈的重組，非教學治療的環境正在不斷變化。臨床上，神經肌肉阻斷的管理正顯著轉向個人化，並輔以客觀的監測工具和通訊協定的給藥方案。這使得藥物作用的可預測性和可靠的逆轉方案變得特別重要，促使醫療機構優先選擇那些藥理特性便於劑量滴定和安全喚醒的藥物。

評估美國將於 2025 年實施的關稅政策對 Atracrium 的供應鏈、成本結構和策略製造因應措施的累積影響。

美國在2025年實施的關稅政策調整，引發了人們對貿易措施對無菌注射劑（包括阿曲庫林）供應和成本動態影響的關注。進口關稅及相關的貿易合規成本可能會增加依賴跨境採購活性成分、添加劑或初級包裝組件的製造商的准入門檻。因此，製造商和合約製造商可能會重新評估其供應基地，考慮近岸外包和供應商多元化，以降低關稅風險並確保無菌生產的連續性。

詳細的細分分析揭示了應用、最終用戶、通路、劑型和給藥途徑如何影響臨床選擇和採購。

細分市場分析揭示了臨床需求、採購行為和產品設計如何微妙地影響Atracrium的發展。按應用領域分析，需求主要集中在兩個方面：重症監護和外科手術。重症監護的需求又延伸至診斷程序和人工呼吸器管理，這兩者都需要為多重器官衰竭患者提供可預測且安全的緩釋肌肉鬆弛劑。外科手術，包括心血管手術、一般外科手術、神經外科手術和整形外科手術，則需要快速起效、持續時間可控且蓄積量低的藥物，以利於術中管理和患者快速恢復。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和跨境因素影響著採購、監管和臨床部署。

區域趨勢對監管預期、供應鏈設計和臨床應用模式有顯著影響。在美洲，大型醫院系統的採購流程往往集中化，重點在於履行合約、確保整個網路產品的一致性以及快速補貨以支援高頻手術。區域法規結構要求嚴格的無菌標準和清晰的臨床標籤，這影響製造商在合規性生產和品質系統方面的投入。

這使人們對製造商、非專利供應商和專業製造商有了策略性的觀點，他們的競爭格局和合作結構會影響 Atracrium 的供應鏈和創新。

Atracrium 的競爭格局包括跨國製藥公司、專業注射劑生產商以及眾多為全球醫療機構供貨的非專利藥生產商。這些企業透過製造地、產品配方和包裝、監管合規記錄以及低溫運輸物流和臨床支援等服務能力來區分彼此。隨著製藥商和醫院集團雙方尋求穩定供應、調整採購獎勵機制以及透過培訓和監測通訊協定將藥品整合到處方集中，雙方之間的策略合作日益普遍。

為醫院採購團隊、麻醉科領導和製造商提供切實可行的優先建議，以降低風險並最佳化臨床和商業性成果。

產業領導者應採取多管齊下的方法，協調臨床優先事項、營運韌性和商業性柔軟性。首先，醫院和採購團隊應制定跨職能通訊協定，整合麻醉科、藥局和供應鏈的觀點，確保產品選擇既體現臨床適用性，又兼顧物流可靠性。這將有助於避免決策分散，並增強應對手術量尖峰時段和加護病房(ICU) 佔用率激增的準備。同時，製造商應注重透明地披露籌資策略、批次追溯和緊急時應對計畫等資訊，以便客戶更好地評估供應風險並做出明智的合約決策。

本報告分析的基礎是穩健的研究框架，其中包括對主要和次要調查的說明、專家檢驗和資料三角測量技術，以確保分析的嚴謹性和可重複性。

本報告的分析整合了第一手定性資料和嚴謹的二手研究，以確保提供可靠且實用的見解。第一手研究包括對麻醉師、重症監護藥劑師、醫院供應鏈經理和法規事務專業人員進行結構化訪談，以收集他們對臨床實踐、採購挑戰和供應商績效的直接看法。這些訪談旨在識別影響產品選擇和庫存管理的實際挑戰、管理重點和營運限制。

匯集臨床、監管和商業性見解，為整個醫療保健系統和製藥公司的決策者提供參考。

阿曲庫林具有可預測的中效作用和非器官依賴性代謝，尤其適用於病情複雜的患者群體，在麻醉和重症監護的治療方案中佔據著重要的地位。這種不斷變化的市場格局受到以下因素的影響：臨床醫生對可調節神經肌肉阻斷劑的偏好、監管機構對無菌注射劑日益成長的關注，以及貿易政策和全球物流趨勢變化加劇的供應鏈壓力。這些因素共同促使臨床醫生、負責人和生產商需要協調一致地應對，以確保安全可靠的用藥途徑。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：吸引器市場：按類型分類

  • 凍乾粉
    • 多劑量管瓶
    • 單劑量管瓶
  • 預填充式注射器

第9章：阿特拉克里瑪市場：依管理途徑

  • 靜脈注射
    • Bolus注
    • 持續輸注

第10章：吸引器市場：依應用分類

  • 重症監護
    • 診斷治療
    • 人工呼吸呼吸系統護理
  • 外科手術
    • 心血管外科
    • 一般外科
    • 神經外科
    • 整形外科手術

第11章：吸引器市場：依最終用戶分類

  • 門診手術中心
    • 醫院附設中心
    • 獨立中心
  • 診所
    • 一般診所
    • 專科診所
  • 醫院
    • 私立醫院
    • 公立醫院

第12章：市集市場：依分銷通路分類

  • 醫院藥房
    • 醫院藥房
    • 外包藥房
  • 網路藥房
    • 非處方藥房
    • 處方箋藥房
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

第13章：課外活動市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：吸引器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：吸引物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國中庭市場

第17章：中國旅遊景點市場

第18章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alkaloids Corporation
  • Baxter Healthcare
  • CF Pharma Ltd.
  • Eugia Pharma
  • Gland Pharma Limited
  • GlaxoSmithKline
  • Global Calcium
  • Hikma Pharmaceuticals
  • Hospira
  • Meitheal Pharmaceuticals
  • Neon Laboratories Ltd.
  • Shandong Boyuan Pharmaceutical Co., Ltd.
  • Synnat Pharma
  • Teva Pharmaceutical Industries
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-9A6A6F297462

The Atracurium Market was valued at USD 251.75 million in 2025 and is projected to grow to USD 267.17 million in 2026, with a CAGR of 4.28%, reaching USD 337.73 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 251.75 million
Estimated Year [2026] USD 267.17 million
Forecast Year [2032] USD 337.73 million
CAGR (%) 4.28%

A concise orientation to atracurium's clinical role, pharmacologic profile, and strategic relevance for hospitals and critical care stakeholders

Atracurium occupies a distinct and enduring role within anesthetic and critical care practice due to its predictable intermediate neuromuscular blockade and metabolism that is largely independent of renal and hepatic function. Clinicians value these pharmacologic attributes for use in complex surgical cases and prolonged intensive care scenarios where organ dysfunction complicates agent selection. Over time, atracurium has transitioned from a niche product to a core option in many formularies because it balances onset and duration with a dependable safety profile, making it especially relevant for patient populations with comorbidities.

Beyond pharmacology, operational considerations increasingly influence atracurium selection. Hospital formularies now weigh supply chain resilience, product presentation, and compatibility with common infusion protocols as heavily as clinical efficacy. This broader lens reflects a shift in decision-making where anesthesiologists, pharmacists, and procurement leaders interact more closely to optimize both clinical outcomes and operational continuity. Consequently, understanding atracurium's clinical utility together with its supply, regulatory, and logistical context is essential for stakeholders who must align therapeutic choice with institutional priorities and changing care pathways.

Emerging clinical practices, regulatory adjustments, and supply chain transformations reshaping atracurium utilization across perioperative and critical care settings

The landscape surrounding atracurium is evolving through a combination of clinical practice shifts, regulatory refinements, and supply chain reconfiguration. Clinically, there is a pronounced movement toward individualized neuromuscular blockade management supported by objective monitoring tools and protocolized dosing strategies. This has elevated the importance of predictable drug behavior and reliable reversal options, driving institutions to prioritize agents whose pharmacologic profiles facilitate titration and safe emergence.

At the same time, regulatory environments are emphasizing quality assurance for injectable products, prompting manufacturers to invest in sterile manufacturing controls and enhanced labeling clarity. These regulatory expectations intersect with supply chain trends where lean inventories are being re-evaluated in favor of buffer strategies that protect critical care continuity. Moreover, the increasing adoption of ambulatory surgery models and expanded procedural volumes in outpatient settings are shifting consumption patterns, with implications for packaging formats and distribution approaches. Together, these forces are prompting manufacturers and health systems to innovate around product presentation, cold chain logistics, and clinician education to maintain reliable access and safe use across diverse care settings.

Assessing the cumulative impact of evolving United States tariff policies in 2025 on atracurium supply chains, cost structures, and strategic manufacturing responses

The introduction of tariff policy adjustments in the United States for 2025 has amplified attention on how trade measures influence the availability and cost dynamics of sterile injectable drugs, including atracurium. Import tariffs and related trade compliance costs can increase landed input costs for manufacturers that rely on cross-border sourcing of active pharmaceutical ingredients, excipients, or primary packaging components. As a result, manufacturers and contract producers may re-evaluate supply footprints, considering nearshoring or diversification of suppliers to mitigate tariff exposure and ensure continuity of sterile production.

In response to tariff-driven cost pressures, manufacturers may adjust commercial strategies by optimizing manufacturing efficiency, renegotiating supplier contracts, or shifting production to jurisdictions with favorable trade terms. Health systems could experience indirect effects through procurement cycles as hospitals and pharmacies seek to buffer against price volatility by consolidating purchasing, increasing reliance on long-term contracts, or expanding use of therapeutic alternatives when clinically appropriate. Importantly, tariff impacts do not occur in isolation; they interact with regulatory compliance costs, inflationary input pressures, and logistics constraints, producing a cumulative effect that requires integrated commercial planning between manufacturers, distributors, and institutional buyers.

Consequently, stakeholders should expect continued scrutiny of supply chain risk and scenario planning. Contract manufacturers and finished-dose producers that proactively communicate sourcing strategies and demonstrate supply resilience will better preserve customer confidence. At the same time, purchasers will increasingly prioritize transparency regarding origin, lot traceability, and contingency plans to manage potential disruptions arising from trade policy shifts.

Granular segmentation interpretation revealing how applications, end users, distribution channels, form factors, and administration routes drive clinical choice and procurement

Segmentation reveals the nuanced pathways through which clinical need, procurement behavior, and product design shape atracurium deployment. When analyzed by application, demand centers on two primary domains: intensive care and surgical procedures. Intensive care requirements bifurcate into diagnostic procedures and mechanical ventilation, each demanding sustained neuromuscular blockade options that are predictable and safe for patients with multi-organ compromise. Surgical procedures encompass cardiovascular surgery, general surgery, neurological surgery, and orthopedic surgery, where rapid onset, controllable duration, and minimal accumulation are central to intraoperative management and timely recovery.

Viewing the market by end user highlights the diverse operational environments where atracurium is utilized. Ambulatory surgery centers, split between hospital-affiliated centers and standalone centers, increasingly seek compact, low-waste packaging and easy-to-administer formats. Clinics, differentiated into general clinics and specialty clinics, emphasize product stability and straightforward dosing. Hospitals, comprising private and public institutions, require scalable supply, robust contract terms, and clear clinical guidelines to support high-acuity use.

Distribution channel analysis underscores the role of hospital pharmacies, online pharmacies, and retail pharmacies in shaping access. In-house hospital pharmacies and outsourced pharmacy services manage sterile compounding and inventory in acute settings. Online pharmacies, both over-the-counter and prescription-focused, affect procurement convenience for lower-acuity settings, while chain and independent retail pharmacies support outpatient transitions and perioperative medication needs. Form-based segmentation between lyophilized powder and pre-filled syringes, with lyophilized options presented as multi-dose and single-dose vials and pre-filled syringes typically packaged as single-dose syringes, influences preparation time, waste, and dosing precision. Finally, route of administration considerations focus on intravenous delivery, with clinicians choosing between bolus injection and continuous infusion approaches according to procedural requirements and patient physiology.

Taken together, these segmentation lenses provide a multi-dimensional understanding of where product improvements, packaging innovations, and distribution optimizations can most effectively reduce waste, improve safety, and align with clinician workflows.

Regional dynamics and cross-border considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping procurement, regulation, and clinical adoption

Regional dynamics exert a strong influence on regulatory expectations, supply chain design, and clinical adoption patterns. In the Americas, procurement processes tend to be centralized for large hospital systems, with an emphasis on contract performance, product uniformity across networks, and rapid replenishment to support high-procedure volumes. Regulatory frameworks in this region demand stringent sterility standards and clear clinical labeling, which in turn shape manufacturer investments in compliant production and quality systems.

Across Europe, the Middle East & Africa, regulatory heterogeneity and variable logistics infrastructure require adaptable supply strategies. In many markets within this combined region, local regulatory approvals and import requirements create additional steps for market entry, and differences in hospital procurement sophistication can influence the pace of adoption. Manufacturers often tailor packaging and distribution to address cold chain challenges and to ensure compliance with country-specific regulatory and reimbursement environments.

The Asia-Pacific region features a blend of mature urban centers with advanced hospital systems and rapidly developing markets where procedural volumes are expanding. Procurement models range from centralized health system purchasing to fragmented private sector procurement, and manufacturers must balance cost pressures with the need to provide stable supply and clinician support. Collectively, regional variations underscore the importance of market-specific strategies that consider regulatory timelines, distribution reliability, and local clinical practice patterns to ensure consistent access and appropriate clinical use.

Competitive and partnership landscape offering strategic perspective on manufacturers, generic suppliers, and specialty players influencing atracurium availability and innovation

The competitive environment for atracurium consists of multinational pharmaceutical firms, specialty injectable manufacturers, and a broad set of generic producers that supply institutions across global markets. These players differentiate themselves through manufacturing footprint, product formulation and packaging, regulatory compliance track record, and service capabilities such as cold chain logistics and clinical support. Strategic partnerships between manufacturers and hospital groups have become more common as both parties seek to stabilize supply, align procurement incentives, and support formulary integration with training and monitoring protocols.

Innovation in this landscape is often incremental and focused on improving delivery formats, reducing preparation complexity, and enhancing sterility assurance. Some manufacturers emphasize multi-dose vial designs to reduce per-dose costs in high-volume settings, while others prioritize single-dose vials or pre-filled syringes that minimize medication errors and preparation time in ambulatory and procedural environments. Additionally, contract manufacturing organizations and specialized sterile injectables providers play a critical role by offering capacity and redundancy, which can be decisive when primary manufacturers face production constraints.

For purchasers, evaluating suppliers involves not only product characteristics but also demonstrated reliability, transparency around supply sources, and agility in responding to demand shifts. Vendor selection increasingly factors in quality metrics, recall history, and the ability to support clinical education and stewardship programs that promote appropriate use and minimize waste.

Practical, prioritized recommendations enabling hospital procurement teams, anesthesiology leaders, and manufacturers to mitigate risk and optimize clinical and commercial outcomes

Industry leaders should adopt a multi-pronged approach that aligns clinical priorities with operational resilience and commercial flexibility. First, hospitals and procurement teams ought to formalize cross-functional protocols that integrate anesthesiology, pharmacy, and supply chain perspectives to ensure product selection reflects both clinical suitability and logistical reliability. This helps avoid fragmented decision-making and improves readiness for surgical peaks or ICU surges. In parallel, manufacturers should invest in transparent communication about sourcing strategies, lot traceability, and contingency plans so customers can better assess supply risk and make informed contracting decisions.

Second, stakeholders should prioritize product presentations that reduce preparation time and medication waste. Transitioning appropriate care settings toward single-dose, ready-to-administer formats can improve safety and operating room throughput, while multi-dose offerings remain relevant in high-volume inpatient contexts. Third, building strategic inventory buffers and diversified supplier relationships will mitigate exposure to trade policy shifts and production interruptions. Strategic contracting that balances price with service-level commitments, expedited shipping provisions, and access to safety stock will be critical.

Finally, clinical stewardship must be enhanced through education on neuromuscular monitoring and protocolized dosing to reduce overuse and adverse events. Manufacturers and healthcare organizations can collaborate to provide training and tools that support safe titration and minimize residual blockade. By aligning clinical best practices with procurement and manufacturing strategies, the sector can strengthen both patient outcomes and supply stability.

Robust research framework describing primary and secondary approaches, expert validation, and data triangulation used to ensure analytical rigor and reproducibility

The analysis underpinning this report synthesizes primary qualitative inputs and rigorous secondary validation to ensure robust and actionable findings. Primary research included structured interviews with anesthesiologists, critical care pharmacists, hospital supply chain directors, and regulatory affairs specialists to capture firsthand perspectives on clinical practice, procurement challenges, and supplier performance. These interviews were conducted to identify real-world pain points, stewardship priorities, and operational constraints that shape product selection and inventory management.

Secondary research involved systematic review of regulatory guidance, sterile manufacturing standards, and publicly available clinical literature to corroborate interview insights and contextualize practice trends. Data triangulation methods were applied to reconcile differing perspectives and to identify consistent themes across geographies and care settings. Quality controls included cross-validation of supplier claims, review of adverse event reporting trends, and assessment of packaging and administration protocols to ensure conclusions reflect both clinical realities and logistical imperatives.

Finally, content was peer-reviewed by independent clinical and supply chain experts to verify the accuracy and applicability of recommendations. This layered methodology provides decision-makers with a credible foundation for strategic planning, procurement policy development, and clinical program design.

Synthesis of clinical, regulatory, and commercial insights summarizing implications for decision-makers across healthcare systems and pharmaceutical manufacturers

Atracurium occupies a valuable niche in the therapeutic toolkit for anesthesia and critical care because of its predictable intermediate action and organ-independent metabolism, attributes that are particularly advantageous in complex patient populations. The evolving landscape is shaped by clinical preferences for titratable neuromuscular blockade, heightened regulatory focus on sterile injectables, and supply chain pressures intensified by trade policy changes and global logistics dynamics. These converging factors require coordinated responses from clinicians, procurement professionals, and manufacturers to maintain safe and reliable access.

Decision-makers should view atracurium strategy holistically, integrating evidence-based clinical protocols with procurement policies that emphasize supplier transparency and contingency capacity. Investments in monitoring technologies and clinician education will reduce variability in use and improve patient safety, while packaging innovation and distribution partnerships can address operational efficiency and waste reduction. Ultimately, aligning clinical imperatives with supply resilience will be central to ensuring that atracurium remains a dependable option across perioperative and intensive care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Atracurium Market, by Form

  • 8.1. Lyophilized Powder
    • 8.1.1. Multi Dose Vial
    • 8.1.2. Single Dose Vial
  • 8.2. Pre-Filled Syringe

9. Atracurium Market, by Route Of Administration

  • 9.1. Intravenous
    • 9.1.1. Bolus Injection
    • 9.1.2. Continuous Infusion

10. Atracurium Market, by Application

  • 10.1. Intensive Care
    • 10.1.1. Diagnostic Procedures
    • 10.1.2. Mechanical Ventilation
  • 10.2. Surgical Procedures
    • 10.2.1. Cardiovascular Surgery
    • 10.2.2. General Surgery
    • 10.2.3. Neurological Surgery
    • 10.2.4. Orthopedic Surgery

11. Atracurium Market, by End User

  • 11.1. Ambulatory Surgery Centers
    • 11.1.1. Hospital Affiliated Centers
    • 11.1.2. Standalone Centers
  • 11.2. Clinics
    • 11.2.1. General Clinics
    • 11.2.2. Specialty Clinics
  • 11.3. Hospitals
    • 11.3.1. Private Hospitals
    • 11.3.2. Public Hospitals

12. Atracurium Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
    • 12.1.1. In-House Pharmacy
    • 12.1.2. Outsourced Pharmacy
  • 12.2. Online Pharmacies
    • 12.2.1. Otc Pharmacies
    • 12.2.2. Prescription Pharmacies
  • 12.3. Retail Pharmacies
    • 12.3.1. Chain Pharmacies
    • 12.3.2. Independent Pharmacies

13. Atracurium Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Atracurium Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Atracurium Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Atracurium Market

17. China Atracurium Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alkaloids Corporation
  • 18.6. Baxter Healthcare
  • 18.7. CF Pharma Ltd.
  • 18.8. Eugia Pharma
  • 18.9. Gland Pharma Limited
  • 18.10. GlaxoSmithKline
  • 18.11. Global Calcium
  • 18.12. Hikma Pharmaceuticals
  • 18.13. Hospira
  • 18.14. Meitheal Pharmaceuticals
  • 18.15. Neon Laboratories Ltd.
  • 18.16. Shandong Boyuan Pharmaceutical Co., Ltd.
  • 18.17. Synnat Pharma
  • 18.18. Teva Pharmaceutical Industries
  • 18.19. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ATRACURIUM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ATRACURIUM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATRACURIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ATRACURIUM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL ATRACURIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. GCC ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. GCC ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 277. GCC ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 310. G7 ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 311. G7 ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 312. G7 ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 313. G7 ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 314. G7 ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 315. G7 ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. G7 ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 317. G7 ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 318. G7 ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 319. G7 ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 320. G7 ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 321. G7 ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 322. G7 ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 323. G7 ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 324. G7 ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 325. G7 ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 326. NATO ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 327. NATO ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 328. NATO ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 329. NATO ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 330. NATO ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 331. NATO ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 332. NATO ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 334. NATO ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. NATO ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 336. NATO ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 337. NATO ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 338. NATO ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 339. NATO ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 340. NATO ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 341. NATO ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 342. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 359. CHINA ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 360. CHINA ATRACURIUM MARKET SIZ